Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today announced that abstracts related to lacutamab health-related quality of life and translational data from the ...

"Dosing of the first patient in our ETESIAN study in asthma is a significant milestone, marking our third clinical program ...

By Vijay Kumar Malesu Phase 1b–2 trial evaluates the potential of CAR T-cell therapy obe-cel in relapsed or refractory B-cell ...

Dysregulated cell signaling underlies various diseases, emphasizing the importance of understanding these pathways for ...

A novel CAR T-cell therapy has benefitted patients with relapsed acute lymphoblastic leukemia, showing high response rates in ...

Scientists called for humane ways to handle crabs, lobsters, and other shellfish in the kitchen after showing for the first ...

Roche will acquire Poseida Therapeutics, building on a partnership for CAR T-cell therapies in development for MS and other ...

The original pandemic virus before it was supplanted by SARS-CoV-2 is still influenza. Over the centuries, influenza pandemics have decimated human populations. One of the worst in history is the 1918 ...

Petosemtamab 1500 mg monotherapy phase 2 interim data continues to demonstrate clinically meaningful activity in 2L+ HNSCC - Conference call on Saturday, Dec. 7 at 9:00 a.m. ET to discuss full data ...

A decade after the discovery of CALR, the results are the first for a possible therapy for CALR-mutated MPNs to reach the ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.

This valuable study proposes a novel rapid-entry mechanism of S. aureus that involves the rapid release of calcium from lysosomes. The strength of the paper lies in a very interesting hypothesis; what ...